Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses (ILUVIT)

This study has been completed.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Karoline Krause, Charite University, Berlin, Germany Identifier:
First received: July 26, 2010
Last updated: May 30, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)